Dwayne C. Jones

Array ( [id] => 6835149 [patent_doc_number] => 20030162695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Glucocorticoid blocking agents for increasing blood-brain barrier permeability' [patent_app_type] => new [patent_app_number] => 10/087227 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13088 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162695.pdf [firstpage_image] =>[orig_patent_app_number] => 10087227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695539 [patent_doc_number] => 07071233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases' [patent_app_type] => utility [patent_app_number] => 10/084759 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23177 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071233.pdf [firstpage_image] =>[orig_patent_app_number] => 10084759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931178 [patent_doc_number] => 06979682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast' [patent_app_type] => utility [patent_app_number] => 10/082821 [patent_app_country] => US [patent_app_date] => 2002-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 6656 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979682.pdf [firstpage_image] =>[orig_patent_app_number] => 10082821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009477 [patent_doc_number] => 06900239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Tumor chemopotentiation using isocoumarin derivatives' [patent_app_type] => utility [patent_app_number] => 10/082521 [patent_app_country] => US [patent_app_date] => 2002-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12185 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900239.pdf [firstpage_image] =>[orig_patent_app_number] => 10082521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178204 [patent_doc_number] => 20020156127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Carbamate compounds for use in the treatment of pain' [patent_app_type] => new [patent_app_number] => 10/081943 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4799 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156127.pdf [firstpage_image] =>[orig_patent_app_number] => 10081943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413920 [patent_doc_number] => 20020183335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => '2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators' [patent_app_type] => new [patent_app_number] => 10/075521 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12560 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183335.pdf [firstpage_image] =>[orig_patent_app_number] => 10075521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652144 [patent_doc_number] => 20030105150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method of treating of demyelinating diseases or conditions' [patent_app_type] => new [patent_app_number] => 10/076191 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12668 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105150.pdf [firstpage_image] =>[orig_patent_app_number] => 10076191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669431 [patent_doc_number] => 20030114415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Compositions and methods for treating and preventing memory impairment using citicoline' [patent_app_type] => new [patent_app_number] => 10/073272 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6811 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114415.pdf [firstpage_image] =>[orig_patent_app_number] => 10073272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908173 [patent_doc_number] => 20020143022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Method of inhibiting neoplastic cells with indole derivatives' [patent_app_type] => new [patent_app_number] => 10/071639 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 36370 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20020143022.pdf [firstpage_image] =>[orig_patent_app_number] => 10071639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112616 [patent_doc_number] => 20020173472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Pharmaceutical formulations of resveratrol' [patent_app_type] => new [patent_app_number] => 10/071124 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9122 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173472.pdf [firstpage_image] =>[orig_patent_app_number] => 10071124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248509 [patent_doc_number] => 06673814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents' [patent_app_type] => B2 [patent_app_number] => 10/056913 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10854 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673814.pdf [firstpage_image] =>[orig_patent_app_number] => 10056913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096449 [patent_doc_number] => 06821989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Method of treating certain cancers using an estrogen agonist/antagonist' [patent_app_type] => B2 [patent_app_number] => 10/056397 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10574 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821989.pdf [firstpage_image] =>[orig_patent_app_number] => 10056397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964217 [patent_doc_number] => 06680319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-20 [patent_title] => 'Isoxazolecarboxamide derivatives' [patent_app_type] => B2 [patent_app_number] => 10/052325 [patent_app_country] => US [patent_app_date] => 2002-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21555 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680319.pdf [firstpage_image] =>[orig_patent_app_number] => 10052325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845462 [patent_doc_number] => 20020132847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Inhibition of TNF-alpha-initiated neutrophil response' [patent_app_type] => new [patent_app_number] => 10/044740 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14393 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132847.pdf [firstpage_image] =>[orig_patent_app_number] => 10044740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220940 [patent_doc_number] => 06703423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Inhibition of TNF-initiated neutrophil response' [patent_app_type] => B2 [patent_app_number] => 10/044499 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13790 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 625 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703423.pdf [firstpage_image] =>[orig_patent_app_number] => 10044499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645550 [patent_doc_number] => 06472420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-29 [patent_title] => 'Method for treating a patient with neoplasia by treatment with a paclitaxel derivative' [patent_app_type] => B2 [patent_app_number] => 10/038634 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 9524 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472420.pdf [firstpage_image] =>[orig_patent_app_number] => 10038634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969162 [patent_doc_number] => 20020091157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Method for treating a patient with neoplasla by treatment with a platinum coordination complex' [patent_app_type] => new [patent_app_number] => 10/039154 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9894 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091157.pdf [firstpage_image] =>[orig_patent_app_number] => 10039154 [rel_patent_id] =>[rel_patent_doc_number] =>)